Feasibility Testing of the Alert for Atrial Fibrillation Program

Overview

About this study

The purpose of this study is to determine the psychometric properties of the Knowledge, Attitudes, and Beliefs about Atrial Fibrillation Survey (KABAFS) and to generate critical, practical knowledge about the feasibility of conducting a randomized trial to test the effect of the Alert for Atrial Fibrillation program on treatment-seeking for symptoms of Atrial Fibrillation (AF).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

65 years of age or older
Under the care of providers from the Department of Medicine
English-speaking
Community dwelling,
Have access to and ability to communicate via a telephone
Have one or more risks for developing AF
Not be diagnosed with AF

Exclusion Criteria:

Documented cognitive impairment
Uncompensated hearing or visual deficits
Scheduled for surgery or have undergone a surgical procedure in the last 30 days,
Undergoing active treatment for a malignancy
Receiving hospice care will be excluded

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Pamela McCabe, Ph.D., R.N.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Pamela McCabe, Ph.D., R.N.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials